[Establishment of multiple evidence-integrated evaluation and prediction method for "toxic" Chinese medicines].

Cui, He-Rong; Zhang, Xiao-Yu; You, Liang-Zhen; Zheng, Rui; Chen, Zhao; Jiang, Yin; Zhang, Jing-Jing; Shang, Hong-Cai

Cui, He-Rong; Zhang, Xiao-Yu; You, Liang-Zhen; Zheng, Rui; Chen, Zhao; Jiang, Yin; Zhang, Jing-Jing; Shang, Hong-Cai.

Affiliation

Cui HR; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Zhang XY; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
You LZ; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Zheng R; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Chen Z; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Jiang Y; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Zhang JJ; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Shang HC; Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.

Zhongguo Zhong Yao Za Zhi ; 47(8): 2266-2272, 2022 Apr.

Article in Zh | MEDLINE | ID: mdl-35531744

Subject(s)
Key words

"toxic" Chinese medicine; clinical feature; evidence-based toxicology; multiple evidence; toxicity prediction

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhongguo Zhong Yao Za Zhi Journal subject: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Year: 2022 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google